Company
Immunovant Sciences GmbH
Immunovant Sciences GmbH has 2 drugs tracked on RxWires: 1 in Phase 3, 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| IMVT-1402 | Phase 3 | Generalized Myasthenia Gravis |
| Imeroprubart | Phase 2 | Chronic Inflammatory Demyelinating Polyneuropathy |
Latest
No recent events.
Follow Immunovant Sciences GmbH on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.